Cellular uptake and fate of cationic polymer-coated nanodiamonds delivering siRNA: a mechanistic study.
Jan MajerMarek KindermannDominik PinkasDavid ChvatilPetr CiglerLenka LibusovaPublished in: Nanoscale (2024)
Gene silencing using small interfering RNAs (siRNAs) is a selective and promising approach for treatment of numerous diseases. However, broad applications of siRNAs are compromised by their low stability in a biological environment and limited ability to penetrate cells. Nanodiamonds (NDs) coated with cationic polymers can enable cellular delivery of siRNAs. Recently, we developed a new type of ND coating based on a random copolymer consisting of (2-dimethylaminoethyl) methacrylate (DMAEMA) and N -(2-hydroxypropyl) methacrylamide (HPMA) monomers. These hybrid ND-polymer particles (Cop + -FND) provide near-infrared fluorescence, form stable complexes with siRNA in serum, show low toxicity, and effectively deliver siRNA into cells in vitro and in vivo . Here, we present data on the mechanism of cellular uptake and cell trafficking of Cop + -FND : siRNA complexes and their ability to selectively suppress mRNA levels, as well as their cytotoxicity, viability and colloidal stability. We identified clathrin-mediated endocytosis as the predominant entry mechanism for Cop + -FND : siRNA into U-2 OS human bone osteosarcoma cells, with a substantial fraction of Cop + -FND : siRNA following the lysosome pathway. Cop + -FND : siRNA potently inhibited the target GAPDH gene with negligible toxicity and sufficient colloidal stability. Based on our results, we suggest that Cop + -FND : siRNA can serve as a suitable in vivo delivery system for siRNA.
Keyphrases
- cancer therapy
- induced apoptosis
- hyaluronic acid
- cell cycle arrest
- drug delivery
- gene expression
- endothelial cells
- machine learning
- cell proliferation
- endoplasmic reticulum stress
- dna methylation
- artificial intelligence
- bone mineral density
- deep learning
- bone marrow
- transcription factor
- induced pluripotent stem cells
- smoking cessation
- postmenopausal women
- fluorescent probe
- drug release
- data analysis